Related Experiment Videos
Mutational specificity of benzo[a]pyrene diolepoxide in monkey cells
E Roilides1, J E Gielen, N Tuteja
1Section on Viruses and Cellular Biology, National Institute of Child Health and Human Development, Bethesda, MD 20892.
Mutation Research
|March 1, 1988
Summary
Benzo[a]pyrene diolepoxide (BPDE), a key carcinogen, primarily causes mutations at G.C base pairs in mammalian cells. These mutations, including transversions and deletions, align with BPDE's known binding to guanine residues.
Area of Science:
- Molecular toxicology
- Carcinogenesis research
- Mammalian cell genetics
Background:
- Benzo[a]pyrene diolepoxide (BPDE) is a suspected primary mutagenic and carcinogenic metabolite of benzo[a]pyrene in mammals.
- Understanding BPDE's mutagenic mechanisms is crucial for assessing its carcinogenic potential.
Purpose of the Study:
- To investigate the mutagenic specificity of BPDE in mammalian cells.
- To identify and analyze point mutations induced by BPDE in a shuttle vector system.
Main Methods:
- Utilized the pZ189 shuttle vector system for mutation analysis.
- Replicated BPDE-treated DNA in monkey cells to observe induced mutations.
- Analyzed point mutations at the molecular level.
Main Results:
- Mutations were predominantly observed at G.C base pairs.
- G.C to T.A and G.C to C.G transversions were the most frequent mutation types.
- Single base pair deletions were also frequently observed.
Conclusions:
- The observed mutation pattern strongly correlates with BPDE's known preferential covalent binding to guanine residues.
- BPDE exhibits specific mutagenic activity at G.C sites, supporting its role as a major mutagenic intermediate.